Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers
USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening
Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival
Immunotherapy Demonstrates Disease Control in Phase II Study
Finasteride Does Not Affect Quality of Life, Says Study
Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years
Study: Lack of Sleep Linked With Agressive Breast Cancers
HPV Can Affect Response To Radiation Therapies
Researchers Find 16 Gene Variants Linked to Colorectal Cancer Using CRCgene Database
NCI-Approved CTEP Trials For the Month of September
FDA Approves Imaging Agent For Recurrent Prostate Cancer
Trending Stories
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- In the Headlines: Is oncology ready to move away from animal testing?
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- Imaging’s ride to the bottom in clinical trials—and why it matters now
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out
